Keywords: sanofi, ups, guidance, 2nd-qtr, eps, rises, france
Sanofi ups guidance as 2nd-qtr EPS rises 24.7%
Article | 05 September 2005
France's Sanofi-Aventis, the world's third-largest drugmaker, has reported a 26.0% rise in second-quarter 2005 net income to 1.55 billion euros ($1.89 billion), with earnings ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
